$14.66
-0.34-2.27%
At close: -
$14.73
0.070.48%
After Hours: 5:59 PM EDT
Comments
Loading...
Mineralys Therapeutics Insider Trading Activity | NASDAQ:MLYS | Benzinga
Track the latest Mineralys Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Mineralys Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Mineralys Therapeutics Inc Insiders Doing?
At Mineralys Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 2.50M shares for a total value of $33.70M.
Notable Recent Insider Buys and Sales
- On March 17, 2025, RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, RA Capital Nexus Fund III LP, Peter Kolchinsky, Rajeev Shah, the company's DIRECTOR purchased 1.3M shares for $13.5 each.
- On March 17, 2025, Samsara BioCapital GP LLC, Samsara BioCapital LP, the company's 10% OWNER purchased 600K shares for $13.5 each.
- On March 17, 2025, Srinivas Akkaraju, the company's - purchased 600K shares for $13.5 each.
Ownership Statistics for Mineralys Therapeutics Inc
Shares Outstanding
62.799M
Insider Shares Owned
1.268M
Insider Percentage Owned
2.54%
Institutional Shares Held
11.865M
Institutional Percentage Held
23.8%
| Mar 17, 2025 | Samsara BioCapital GP LLCSamsara BioCapital LP | 10% OWNER | 600.00K | $13.50 | $8.10M | BUY | 11.82% | 5.67M | Mar 13 | View |
| Mar 17, 2025 | Srinivas Akkaraju | — | 600.00K | $13.50 | $8.10M | BUY | 11.82% | 5.67M | Mar 13 | View |
| Mar 17, 2025 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund III LPPeter KolchinskyRajeev Shah | DIRECTOR | 1.30M | $13.50 | $17.50M | BUY | 26.72% | 6.15M | Mar 13 | View |
| Jan 15, 2025 | Adam Levy | CFO AND SECRETARY | -10.76K | $9.10 | -$97.86K | SELL | -4.54% | 226.10K | Jan 13 | View |
| Jan 15, 2025 | Jon Congleton | CHIEF EXECUTIVE OFFICER | -18.33K | $9.06 | -$166.08K | SELL | -2.05% | 877.61K | Jan 13 | View |
| Nov 12, 2024 | Malcom David Rodman | CHIEF MEDICAL OFFICER | 5.02K | $7.91 | -$67.26K | SELL-OPTIONS | 3.69% | 140.99K | Nov 11 | View |
| Nov 08, 2024 | Malcom David Rodman | CHIEF MEDICAL OFFICER | 0.00 | $8.06 | -$355.55K | SELL-OPTIONS | 0.00% | 135.97K | Nov 06 | View |
| Oct 15, 2024 | Adam Levy | CFO AND SECRETARY | -10.76K | $13.57 | -$146.00K | SELL | -4.34% | 236.85K | Oct 11 | View |
| Oct 15, 2024 | Jon Congleton | CHIEF EXECUTIVE OFFICER | -15.27K | $13.52 | -$206.43K | SELL | -1.68% | 895.94K | Oct 11 | View |
| Jul 26, 2024 | Taylor Brian SlingsbyCatalys Pacific Fund LP | DIRECTOR | -550.00K | $13.05 | -$7.18M | SELL | -5.98% | 8.64M | Jul 24 | View |
| Jul 18, 2024 | Malcom David Rodman | CHIEF MEDICAL OFFICER | 0.00 | $8.04 | -$7.31K | SELL-OPTIONS | 0.00% | 102.87K | Jul 16 | View |
| Jul 12, 2024 | Adam Levy | CFO AND SECRETARY | -10.76K | $13.14 | -$141.39K | SELL | -4.16% | 247.61K | Jul 11 | View |
| Jul 12, 2024 | Jon Congleton | CHIEF EXECUTIVE OFFICER | -15.75K | $13.34 | -$210.08K | SELL | -1.70% | 911.21K | Jul 11 | View |
| Jun 20, 2024 | Jon Congleton | CHIEF EXECUTIVE OFFICER | -49.31K | $12.01 | -$592.02K | SELL | -5.05% | 926.96K | Jun 17 - Jun 20 | View |
| Jun 14, 2024 | Jon Congleton | CHIEF EXECUTIVE OFFICER | -72.80K | $12.70 | -$924.20K | SELL | -6.94% | 976.27K | Jun 12 - Jun 14 | View |
| Jun 13, 2024 | Adam Levy | CFO AND SECRETARY | -96.81K | $12.94 | -$1.25M | SELL | -27.48% | 255.46K | Jun 11 | View |
| May 10, 2024 | Malcom David Rodman | CHIEF MEDICAL OFFICER | 0.00 | $8.04 | -$1.39K | SELL-OPTIONS | 0.00% | 67.00K | May 09 | View |
| Feb 14, 2024 | Samsara BioCapital GP LLCSamsara BioCapital LP | 10% OWNER | 555.55K | $13.50 | $7.50M | BUY | 12.29% | 5.07M | Feb 12 | View |
| Nov 27, 2023 | Jon Congleton | CHIEF EXECUTIVE OFFICER | 4.25K | $5.97 | $25.36K | BUY | 0.41% | 1.05M | Nov 22 | View |
| Sep 08, 2023 | Jon Congleton | CHIEF EXECUTIVE OFFICER | 2.25K | $12.08 | $27.18K | BUY | 0.22% | 1.04M | Sep 06 | View |
| Aug 21, 2023 | Jon Congleton | CHIEF EXECUTIVE OFFICER | 2.25K | $12.10 | $27.23K | BUY | 0.22% | 1.04M | Aug 17 | View |
| Aug 11, 2023 | Malcom David Rodman | CHIEF MEDICAL OFFICER | 0.00 | $6.82 | -$2.83M | SELL-OPTIONS | 0.00% | 0.00 | Aug 10 - Aug 11 | View |
| Aug 11, 2023 | Jon Congleton | CHIEF EXECUTIVE OFFICER | 2.00K | $12.89 | $25.78K | BUY | 0.19% | 1.04M | Aug 11 | View |
| Feb 16, 2023 | HBM Healthcare Investments Cayman Ltd | 10% OWNER | 3.22M | $16.00 | $5.00M | BUY | ∞ | 3.22M | Feb 14 | View |
| Feb 16, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund III LPPeter KolchinskyRajeev Shah | DIRECTOR | 3.18M | $16.00 | $20.00M | BUY | ∞ | 1.31M | Feb 14 | View |
| Feb 16, 2023 | Adam Levy | CFO, CHIEF BUS. OFF. AND SECY. | 6.25K | $16.00 | $100.00K | BUY | 1.81% | 350.81K | Feb 14 | View |
| Feb 16, 2023 | SRINIVAS AKKARAJUSamsara BioCapital LP | DIRECTOR | 4.52M | $16.00 | $15.00M | BUY | ∞ | 4.52M | Feb 14 | View |
| Feb 16, 2023 | Taylor Brian SlingsbyCatalys Pacific Fund LP | DIRECTOR | 4.56M | $16.00 | $4.00M | BUY | 98.57% | 9.19M | Feb 14 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.